Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan L Roth

Showing results (41-50 of 450) with videos related to

Pageof 45
Sort By:
The Journal of Clinical Investigation|December 3, 2013
Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugsHerbert Y Meltzer, Bryan L Roth
Brain Research|October 16, 2012
Pharmacosynthetics: Reimagining the pharmacogenetic approachMartilias S Farrell, Bryan L Roth
Biochemical Pharmacology|June 30, 2024
Molecular glues as potential GPCR therapeuticsBryan L Roth, Brian E Krumm
Molecular Cell|July 21, 2023
Built-in functional selectivity in neurons is mediated by the neuronal protein, GINIPNicholas J Kapolka, Bryan L Roth
Annual Review of Neuroscience|July 9, 2014
Chemogenetic tools to interrogate brain functionsScott M Sternson, Bryan L Roth
Cell Chemical Biology|November 17, 2023
CryoEM structures of adhesion in GPCR CD97: Filling in some of the gapsBrian E Krumm, Bryan L Roth
Neuron|August 19, 2021
The cranial windows of perceptionJeffrey F DiBerto, Bryan L Roth
Structure (London, England : 1993)|August 5, 2022
Structural insights from G-protein-coupled receptor complexes enable the rational engineering of improved light-activated designer receptorsNicholas J Kapolka, Bryan L Roth
The Journal of Biological Chemistry|June 24, 2015
Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor SuperfamilyBryan L Roth, Wesley K Kroeze
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 25, 2008
Opportunities and challenges of psychiatric drug discovery: roles for scientists in academic, industry, and government settingsP Jeffrey Conn, Bryan L Roth
Pageof 45

Showing results (41-50 of 450) with videos related to

Sort By:
Pageof 45
The Journal of Clinical Investigation|December 3, 2013
Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugsHerbert Y Meltzer, Bryan L Roth
Brain Research|October 16, 2012
Pharmacosynthetics: Reimagining the pharmacogenetic approachMartilias S Farrell, Bryan L Roth
Biochemical Pharmacology|June 30, 2024
Molecular glues as potential GPCR therapeuticsBryan L Roth, Brian E Krumm
Molecular Cell|July 21, 2023
Built-in functional selectivity in neurons is mediated by the neuronal protein, GINIPNicholas J Kapolka, Bryan L Roth
Annual Review of Neuroscience|July 9, 2014
Chemogenetic tools to interrogate brain functionsScott M Sternson, Bryan L Roth
Cell Chemical Biology|November 17, 2023
CryoEM structures of adhesion in GPCR CD97: Filling in some of the gapsBrian E Krumm, Bryan L Roth
Neuron|August 19, 2021
The cranial windows of perceptionJeffrey F DiBerto, Bryan L Roth
Structure (London, England : 1993)|August 5, 2022
Structural insights from G-protein-coupled receptor complexes enable the rational engineering of improved light-activated designer receptorsNicholas J Kapolka, Bryan L Roth
The Journal of Biological Chemistry|June 24, 2015
Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor SuperfamilyBryan L Roth, Wesley K Kroeze
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 25, 2008
Opportunities and challenges of psychiatric drug discovery: roles for scientists in academic, industry, and government settingsP Jeffrey Conn, Bryan L Roth
Pageof 45